Cardiac Allograft Vasculopathy
📧 Sign up to get email alerts when something new happens for Cardiac Allograft Vasculopathy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-08-18Clinical Trial Results: Cardiac Allograft Vasculopathy Inhibition With Alirocumab [Phase 2]
Phase 2 trial evaluating alirocumab for inhibition of cardiac allograft vasculopathy; results completed with posted results.
-
CLINICAL_TRIALS trial_result · 2026-03-17Clinical Trial Update: Cardiac Allograft Vasculopathy Inhibition With Alirocumab [Phase 2]
Phase 2 trial update evaluating alirocumab for inhibition of cardiac allograft vasculopathy has completed.
-
CLINICAL_TRIALS trial_result · 2024-08-21Clinical Trial Update: Advanced Cardiac Imaging in Cardiac Allograft Vasculopathy
A clinical trial evaluating advanced cardiac imaging for cardiac allograft vasculopathy in heart transplant recipients has been terminated.
-
CLINICAL_TRIALS trial_result · 2024-08-13Clinical Trial Update: Extracorporeal Photopheresis and Early Cardiac Graft Vasculopathy [NA]
A completed clinical trial evaluating extracorporeal photopheresis for cardiac allograft vasculopathy and heart transplant rejection.
-
CLINICAL_TRIALS trial_result · 2024-06-03Clinical Trial Update: Impact of Evolocumab in Cardiac Transplant Patients With CAV [Phase 2]
A Phase 2 trial evaluating evolocumab in heart transplant recipients with cardiac allograft vasculopathy has posted results.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-03-12Clinical Trial Update: Endothelin-1 and Cardiac Allograft Vasculopathy (CAV) [Phase 4]
Phase 4 clinical trial update on Endothelin-1 for Cardiac Allograft Vasculopathy has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-11-01Clinical Trial Update: Cholesterol Lowering With EVOLocumab to Prevent Cardiac Allograft Vasculopathy in De-novo Heart Transplant Recipients [Phase 3]
Phase 3 trial evaluating evolocumab to prevent cardiac allograft vasculopathy in de novo heart transplant recipients has completed.
-
CLINICAL_TRIALS trial_result · 2023-10-03Clinical Trial Update: Efficacy and Safety Of Alirocumab to Prevent Early Cardiac Allograft Vasculopathy in Recent Heart Transplant Recipients [Phase 4]
Phase 4 trial update investigating efficacy and safety of alirocumab to prevent early cardiac allograft vasculopathy in recent heart transpl…
-
CLINICAL_TRIALS trial_result · 2021-09-30Clinical Trial Update: Safety and Efficacy of Everolimus - Eluting Bioresorbable Vascular Scaffold for Cardiac Allograft Vasculopathy [Phase 4]
Phase 4 trial update on safety and efficacy of everolimus-eluting bioresorbable vascular scaffold for cardiac allograft vasculopathy has bee…
-
CLINICAL_TRIALS trial_result · 2021-05-03Clinical Trial Update: The De-novo Use of Eculizumab in Presensitized Patients Receiving Cardiac Transplantation [Phase 3]
Phase 3 trial evaluating de-novo use of eculizumab in presensitized cardiac transplant patients completed; results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2019-06-20Clinical Trial Update: Real Time Myocardial Perfusion Echocardiography for Coronary Allograft Vasculopathy [Phase 4]
Phase 4 clinical trial evaluating real-time myocardial perfusion echocardiography for monitoring cardiac allograft vasculopathy has complete…
-
CLINICAL_TRIALS trial_result · 2019-03-05Clinical Trial Update: Effect of Ivabradine on Exercise Capacity After Heart Transplantation [Phase 4]
Phase 4 clinical trial evaluating the effect of ivabradine on exercise capacity after heart transplantation.
-
CLINICAL_TRIALS trial_result · 2017-08-31Clinical Trial Update: Optical Coherence Tomography (OCT) to Evaluate Cardiac Allograft Vasculopathy (CAV) in Patient's Post Heart Transplant
A completed clinical trial used Optical Coherence Tomography to evaluate cardiac allograft vasculopathy in patients after heart transplantat…
-
CLINICAL_TRIALS trial_result · 2017-04-11Clinical Trial Update: Prevention of Cardiac Allograft Vasculopathy Using Rituximab (Rituxan) Therapy in Cardiac Transplantation [Phase 2]
Phase 2 trial investigating rituximab therapy to prevent cardiac allograft vasculopathy in heart transplant recipients; the study was termin…
-
CLINICAL_TRIALS trial_result · 2017-02-23Clinical Trial Update: Mesenchymal Stem Cell Administration in the Treatment of Coronary Graft Disease in Heart Transplant Patients [Phase 1, Phase 2]
Phase 1/2 trial evaluating mesenchymal stem cell therapy for coronary graft disease in heart transplant patients is currently suspended.
-
CLINICAL_TRIALS trial_result · 2016-08-18Clinical Trial Update: Clinical Trial of Pioglitazone for Prevention of Cardiac Allograft Vasculopathy After Heart Transplantation [Phase 2]
A Phase 2 trial evaluating pioglitazone to prevent cardiac allograft vasculopathy after heart transplantation has completed, with results po…
-
CLINICAL_TRIALS trial_result · 2016-07-27Clinical Trial Update: Angiotensin Converting Enzyme (ACE) Inhibition and Cardiac Allograft Vasculopathy [NA]
A completed clinical trial evaluating the effect of Angiotensin Converting Enzyme (ACE) inhibition on Cardiac Allograft Vasculopathy, with r…
-
CLINICAL_TRIALS trial_result · 2014-10-02Clinical Trial Update: Intracoronary Analysis of Cardiac Allograft Vasculopathy by Means of Optical Coherence Tomography [Phase 4]
This is a Phase 4 clinical trial update from the University of Zurich. The study uses intracoronary optical coherence tomography to analyze …
-
CLINICAL_TRIALS trial_result · 2014-05-09Clinical Trial Update: Assessment of Cardiac Allograft Vasculopathy With Optical Coherence Tomography
This completed clinical trial evaluated the use of optical coherence tomography to assess cardiac allograft vasculopathy.
-
CLINICAL_TRIALS trial_result · 2010-07-12Clinical Trial Update: Safety/Efficacy of Everolimus and Neoral® in Adult Cardiac Transplant Patients With Established Allograft Vasculopathy [Phase 3]
A completed Phase 3 trial evaluating the safety and efficacy of everolimus in combination with cyclosporine (Neoral) in adult heart transpla…
-
CLINICAL_TRIALS trial_result · 2009-01-30Clinical Trial Update: Study to Evaluate Effect of Everolimus in Progression of Graft Vascular Illness on Patients With Heart Transplant [Phase 4]
This Phase 4 clinical trial is evaluating everolimus for progression of graft vascular disease in heart transplant recipients.